Kyushu University Academic Staff Educational and Research Activities Database
Researcher information (To researchers) Need Help? How to update
Shiraishi Yoshimasa Last modified date:2022.06.23



Other Organization


E-Mail *Since the e-mail address is not displayed in Internet Explorer, please use another web browser:Google Chrome, safari.
Phone
092-642-3578
Fax
092-642-5390
Academic Degree
Bachelor of Medicine
Field of Specialization
Respiratory medicine
Total Priod of education and research career in the foreign country
00years00months
Outline Activities
I practice at the Cancer Center and the Department of Respiratory Medicine of Kyushu University Hospital. I am involved in the operation and management of outpatient chemotherapy rooms and the reiview of chemotherapy regimens at Kyushu University Hospital. Lectures on ward training for fifth-year undergraduate students and guidance from residents are also provided. As clinical researches, I serve as the research office for six investigator initiated clinical trials.
Research
Research Interests
  • To develop new treatments for lung cancer and establish standard treatments through various clinical trials.

    keyword : lung cancer, clinical trial, immune checkpoint inhibitor, chemotherapy
    2022.03~2027.03.
Academic Activities
Papers
1. Shiraishi Yoshimasa, Kishimoto Junji, Tanaka Kentaro, Sugawara Shunichi, Daga Haruko, Hirano Katsuya, Azuma Koichi, Hataji Osamu, Hayashi Hidetoshi, Tachihara Motoko, Mitsudomi Tetsuya, Seto Takashi, Nakagawa Kazuhiko, Yamamoto Nobuyuki, Okamoto, Isamu, Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer, CLINICAL LUNG CANCER, 10.1016/j.cllc.2020.03.010, 21, 5, 472-476, 2020.09.
2. Tsuchiya-Kawano Yuko, Shiraishi Yoshimasa, Kiyomi Fumiaki, Okamoto Isamu, Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naive Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LOGiK2004), CANCER MANAGEMENT AND RESEARCH, 10.2147/CMAR.S341287, 13, 8489-8493, 2021.11.
Presentations
1. Yoshimasa Shiraishi, Haruko Daga, Satoshi Ikeda, Akito Hata, Hideaki Mizutani, Tomohiro Sakamoto, Haruhiro Saito, Osamu Hataji, Hiroshi Tanaka, Atsushi Horiike, Hideo Saka, Tsuneo Shimokawa, Masahide Mori, Katsuya Hirano, Koichi Azuma, Tetsuya Mitsudomi, Takashi Seto, Nobuyuki Yamamoto, Kazuhiko Nakagawa, Isamu Okamoto, A multicenter, open label, randomized phase III study of atezolizumab with platinum-pemetrexed and with or without bevacizumab for patients with advanced nonsquamous non-small cell lung cancer (WJOG11218L APPLE Study)., American Society of Clinical Oncology, 2019.06.
2. Yoshimasa Shiraishi, Akito Hata, Naoki Inui, Morihito Okada, Masahiro Morise, Kohei Akiyoshi, Masayuki Takeda, Yasutaka Watanabe, Shunichi Sugawara, Naofumi Shinagawa, Kaoru Kubota, Toshiaki Saeki, Tomohide Tamura, Multicenter, double-blind, randomized phase 3 study of fosnetupitant compared with fosaprepitant for the prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin based highly emetogenic chemotherapy: CONSOLE., American Society of Clinical Oncology, 2021.06.
Educational
Educational Activities
I teach young doctors and nurses at the Cancer Center and the Department of Respiratory Medicine of Kyushu University Hospital, lectures on ward training for fifth-year undergraduate students, and guidance for residents. In addition, three cancer-related graduate school lectures will be held this year.